190 filings
Page 5 of 10
8-K
c553e5jxtg68y 3n5qq
1 Jun 22
Regulation FD Disclosure
7:08am
8-K
c6jd6i bhr9k5l1
19 May 22
Clene Receives $3 Million Loan from State of Maryland to Support
4:07pm
8-K
7wp9o0i3m qfqto8
9 May 22
Clene Reports First Quarter 2022 Financial Results and Recent Operating Highlights
8:03am
8-K
p4gootgfxpqor58c
6 May 22
Submission of Matters to a Vote of Security Holders
4:12pm
EFFECT
w32z dvx0runeivl3
27 Apr 22
Notice of effectiveness
12:15am
424B5
ggbrkgz ku2qgjxsossn
26 Apr 22
Prospectus supplement for primary offering
5:21pm
CORRESP
mzhzv05d7mwto
22 Apr 22
Correspondence with SEC
12:00am
8-K
c1pj3it3w50ye
18 Apr 22
Regulation FD Disclosure
8:07am
UPLOAD
jiwms4gn2 ea
18 Apr 22
Letter from SEC
12:00am
S-3
mno1jilh
14 Apr 22
Shelf registration
4:56pm
8-K
u950kl pjc6a7m06tck
14 Apr 22
Entry into a Material Definitive Agreement
4:02pm
8-K
brc9d6jv
5 Apr 22
Regulation FD Disclosure
4:07pm
DEFA14A
it8jv t7i49bn
29 Mar 22
Additional proxy soliciting materials
4:15pm
8-K
db1negze88c733iliv4
14 Mar 22
Interim results demonstrate approximately 70% decreased risk of death for participants who entered the RESCUE-ALS long-term open label extension
7:02am
8-K
nyvouepv y89sub787ox
11 Mar 22
Clene Reports Full Year 2021 Financial Results and Recent Operating Highlights
7:04am
8-K
0uf2ch9varbcmow9qfk
24 Feb 22
Clene Nanomedicine Presents Data from Two Phase 2 Multiple Sclerosis Trials at ACTRIMS Forum 2022
7:02am
8-K
68mp5910fqix2bvgdi5
15 Feb 22
Clene Nanomedicine Provides Clinical Program Update
7:01am